Nike Tariff Refund Lawsuit Sparks Consumer Backlash Over Price Increases 
Goldman Sachs Delays Fed Rate Cut Forecast to 2026 Amid Rising Inflation Concerns 
Trump Says Iran Ceasefire ‘On Life Support’ as Oil Prices Surge Above $104 
China Car Sales Drop Again as EV Export Growth Surges in April 
Trump Rejects Iran Proposal as Strait of Hormuz Crisis Pushes Oil Prices Higher 
US, Japan Reaffirm Strong Currency Coordination Amid Yen Volatility 
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles 
Asian Currencies Slide as Indian Rupee Hits Record Low Amid Iran Tensions 
Neuralink Expands Brain Implant Trials with 12 Global Patients 
Asian Stocks Slip as Korea’s KOSPI Tumbles Amid Iran Conflict and Chip Sector Profit-Taking 
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit 
US Auto Industry Urges Trump to Block Chinese EV Market Access 
AcadeMedia Q3 Profit Climbs as International and Adult Education Segments Drive Growth 
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
Gold Prices Slip as Strong Dollar and Rising Oil Weigh on Market Sentiment 
South Korea will invest 274.6 billion won in the bio-industry this year for 252 new R&D projects in the four fields of biopharmaceuticals, healthcare, biomaterials, and medical equipment in 2023.
According to South Korea’s Ministry of Trade, Industry and Energy, 94.8 billion won would be allocated to developing new medicines, microbiome analysis, and other biomanufacturing process technology.
Around 69.5 billion won will support the development of advanced medical appliances, and 30 billion won will be for developing state-of-the-art biomaterials.
The ministry added that beefing up support for biomaterials and other new fields of the sector would promote innovation.
